Lyra Therapeutics, Inc. (LYRA)
USD 0.17
(-6.54%)
USD 0.17
(-6.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.55 Million | 1.36 Million | 285 Thousand | - | - | 1.24 Million |
| Cost of Revenue | 48.02 Million | 1.06 Million | 1 Million | 95 Thousand | 27 Thousand | - |
| Gross Profit | -46.47 Million | 296 Thousand | -715.99 Thousand | -95 Thousand | -27 Thousand | 1.24 Million |
| Operating Expenses | 20.64 Million | 56.35 Million | 43.9 Million | 22.2 Million | 16.51 Million | 8.5 Million |
| Selling, General and Administrative Expenses | 19.05 Million | 17.55 Million | 14.2 Million | 9.68 Million | 4.48 Million | 3.52 Million |
| Research and Development Expenses | 48.02 Million | 38.79 Million | 29.69 Million | 12.52 Million | 12.03 Million | 4.97 Million |
| Other Expenses | -46.43 Million | 1.31 Million | - | - | - | 1.19 Million |
| Cost and Expenses | 68.67 Million | 56.35 Million | 43.9 Million | 22.2 Million | 16.51 Million | 8.5 Million |
| Operating Income | -67.12 Million | -56.3 Million | -43.61 Million | -22.2 Million | -16.51 Million | -7.25 Million |
| Interest Expense | - | 524 Thousand | - | - | - | - |
| Income Tax Expense | 59 Thousand | 13 Thousand | -1.1 Million | -82 Thousand | -213 Thousand | -1.23 Million |
| Earnings before Tax | -62.62 Million | -55.26 Million | -43.51 Million | -22.12 Million | -16.3 Million | -6.02 Million |
| Net Income | -62.68 Million | -55.27 Million | -42.41 Million | -22.04 Million | -16.09 Million | -6.02 Million |
| Earnings Per Share Basic | -1.26 | -1.83 | -3.27 | -2.57 | -1.25 | -0.96 |
| Earnings Per Share Diluted | -1.26 | -1.83 | -3.27 | -2.57 | -1.25 | -0.96 |
| Weighted Average Shares Outstanding | 49.8 Million | 30.23 Million | 12.98 Million | 8.59 Million | 12.92 Million | 6.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.8 Million | 30.23 Million | 12.98 Million | 8.59 Million | 12.92 Million | 6.26 Million |
| Gross Margin | -29.83 | 0.22 | -2.51 | - | - | 1.00 |
| EBIT Margin | -41.88 | -39.38 | -153.04 | - | - | -5.77 |
| Profit Margin | -40.23 | -40.56 | -148.81 | - | - | -4.85 |
| EBITDA | -65.25 Million | -53.92 Million | -42.61 Million | -22.11 Million | -16.49 Million | -7.17 Million |
| Earnings Before Tax Margin | -43.08 | -41.31 | -153.04 | - | - | -5.84 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 598 Thousand | 532 Thousand | 1.55 Million | 146 Thousand | 544 Thousand | 458 Thousand |
| Cost of Revenue | 145 Thousand | 136 Thousand | 278 Thousand | 85 Thousand | 12.36 Million | 10.79 Million |
| Gross Profit | 453 Thousand | 396 Thousand | 1.28 Million | 61 Thousand | -11.82 Million | -10.34 Million |
| Operating Expenses | 18.25 Million | 23.92 Million | 66.8 Million | 16.53 Million | 17.37 Million | 15.36 Million |
| Selling, General and Administrative Expenses | 5.13 Million | 5.81 Million | - | 4.35 Million | 5 Million | 4.57 Million |
| Research and Development Expenses | 13.11 Million | 18.1 Million | - | 12.18 Million | 12.36 Million | 10.79 Million |
| Other Expenses | 29.28 Million | - | 1.59 Million | - | - | 1.59 Million |
| Cost and Expenses | 18.4 Million | 24.05 Million | 67.08 Million | 16.62 Million | 17.37 Million | 15.36 Million |
| Operating Income | -17.8 Million | -23.52 Million | -65.52 Million | -16.47 Million | -16.82 Million | -16.5 Million |
| Interest Expense | - | - | - | 1.07 Million | - | - |
| Income Tax Expense | 12 Thousand | 14 Thousand | 59 Thousand | 17 Thousand | -16 Thousand | 12 Thousand |
| Earnings before Tax | -48.11 Million | -22.43 Million | -62.62 Million | -15.13 Million | -15.63 Million | -15.6 Million |
| Net Income | -48.13 Million | -22.45 Million | -62.68 Million | -15.15 Million | -15.65 Million | -15.61 Million |
| Earnings Per Share Basic | -0.74 | -0.35 | - | -0.26 | -0.27 | -0.36 |
| Earnings Per Share Diluted | -0.74 | -0.35 | - | -0.26 | -0.27 | -0.36 |
| Weighted Average Shares Outstanding | 65.45 Million | 64.01 Million | 49.8 Million | 57.21 Million | 56.95 Million | 43.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 65.45 Million | 64.01 Million | 49.8 Million | 57.21 Million | 56.95 Million | 43.67 Million |
| Gross Margin | 0.76 | 0.74 | 0.82 | 0.42 | -21.74 | -22.58 |
| EBIT Margin | -29.53 | -43.96 | - | -112.27 | -30.93 | -29.08 |
| Profit Margin | -80.49 | -42.20 | -40.23 | -103.81 | -28.77 | -34.10 |
| EBITDA | -17.66 Million | -23.38 Million | - | -16.39 Million | -16.82 Million | -13.31 Million |
| Earnings Before Tax Margin | -29.77 | -44.22 | -42.06 | -112.86 | -30.93 | -36.03 |
AMNF
2466
BIM
ASPN
1321
601880